VARS1
protein-codingvalyl-tRNA synthetase 1, the group of Aminoacyl tRNA synthetases, Class I
Gene summary
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. The protein encoded by this gene belongs to class-I aminoacyl-tRNA synthetase family and is located in the class III region of the major histocompatibility complex. [provided by RefSeq, Jul 2008]
- VARS2
- VARS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~18.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0060621
Submitter: ClinGen
The VARS1 gene is located on chromosome 6 at 6p21.33 and encodes the valyl-tRNA synthetase 1 protein. VARS1 plays a key role in protein translation as the cytoplasmic aminoacyl-tRNA synthetase responsible for catalyzing the attachment of valine to its cognate transfer RNA (tRNA) molecule. VARS1 was first reported in relation to autosomal recessive neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy in 2015 (Karaca et al. 2015 26539891). The disorder is characterized by a severe global developmental delay, acquired microcephaly (typically present by 6 months of age) and an onset of seizures during early infancy (Friedman et al. 2019; Siekierska et al. 2019). Seizure types vary between affected cases and may include myoclonia, focal clonic seizures and or generalized seizures. Brain abnormalities detected by MRI are also variable, cortical atrophy being the most common feature. Partial agenesis or hypoplasia of the corpus callosum are frequently seen, as well as cerebellar atrophy. Seventeen variants (including 14 missense, 1 frameshift, 1 stop gained and 1 canonical splice site variant), that have been reported in 12 probands in five publications (PMIDs: 26539891, 29137650, 29691655, 30755616, 30755602) are included in this curation. The mechanism of disease is biallelic loss of function. This gene-disease relationship is also supported by expression studies and other aminoacyl-tRNA synthetases have been associated with gene disease relationships characterized neurodevelopmental phenotypes (PMID: 25035493). A zebrafish vars1 knockout model, generated using CRISPR/Cas9 technology, recapitulates the brain malformation, developmental delay and seizure phenotypes observed in the clinical phenotype. In summary, there is definitive evidence to support the relationship between VARS1 and autosomal recessive neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date December 6th, 2023 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0014397
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0060621
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0060621
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to VARS1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006295.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 27 | 5 | 38 | ||
| missense | 4 | 16 | 234 | 15 | 5 | 274 |
| nonsense | 5 | 6 | 3 | 14 | ||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 2 | 7 | ||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 5 | 10 | ||
| Total | 14 | 27 | 250 | 42 | 10 | 343 |
Highest pathogenic variant AF is 0.00007502145
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006286.1 | 29 | MANE Select | |
| Ensembl | ENSP00000364815.3 | 29 | MANE Select | |
| Ensembl | ENSP00000415679.1 | 10 | Standard | |
| Ensembl | ENSP00000413925.1 | 2 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| vars | Danio rerio | Structure: head Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
- Amino Acid metabolism
- tRNA Aminoacylation
- Translation
- Metabolism of proteins
Biological Process
- tRNA aminoacylation for protein translation
- valyl-tRNA aminoacylation
- aminoacyl-tRNA metabolism involved in translational fidelity
Molecular Function
- aminoacyl-tRNA editing activity
- valine-tRNA ligase activity
- protein binding
- ATP binding
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375663
- Coding exons
- 29
- Length
- 18436
- Individuals with no LoFs
- 125634
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 114
- Defined
- 125748
- p
- 0.000453
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.68 | 577 | 789 | 0.731 | 0.0000509 | 8069 |
| Missense (PolyPhen) | 193 | 327.57 | 0.58919 | 3481 | ||
| Synonymous | 1.99 | 274 | 319 | 0.859 | 0.0000197 | 2679 |
| Loss of Function | 4.98 | 27 | 72.9 | 0.370 | 0.00000387 | 739 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.0023 | 0.0023 | notable |
| European (Non-Finnish) | 0.00039 | 0.00038 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy (NDMSCA) [MIM:617802]: An autosomal recessive neurodevelopmental disorder characterized by severe developmental delay, intellectual disability, severe microcephaly, and cortical atrophy. {ECO:0000269|PubMed:26539891}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0913
Intolerance Scores
- LoFtool
- 0.626
- RVIS EVS
- -0.33
- RVIS percentile EVS
- 30.9
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |